OOIR: Observatory of International Research

Papers

(The median citation count of Current Rheumatology Reports is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
COVID-19 and Myositis: What We Know So Far	102
A Review of Complement Activation in SLE	89
Systemic Lupus Erythematosus in Children and Young People	78
Epidemiology of Antiphospholipid Syndrome in the General Population	70
T Cell Abnormalities in the Pathogenesis of Systemic Lupus Erythematosus: an Update	62
Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease	36
Diffuse Idiopathic Skeletal Hyperostosis (DISH) and a Possible Inflammatory Component	35
Fatty Acids and Oxylipins in Osteoarthritis and Rheumatoid Arthritis—a Complex Field with Significant Potential for Future Treatments	35
Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens	34
The Use of COVID-19 Vaccines in Patients with SLE	34
Current Epidemiology and Risk Factors for the Development of Hand Osteoarthritis	34
Advances in the Treatment of Behcet’s Disease	32
Clinical Approach to Diagnosis and Therapy of Polyarteritis Nodosa	32
Dietary and Lifestyle-Centered Approach in Gout Care and Prevention	31
Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides	30
Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled Trials	29
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?	29
T cell Repertoire Profiling and the Mechanism by which HLA-B27 Causes Ankylosing Spondylitis	28
Re-Examining Myofascial Pain Syndrome: Toward Biomarker Development and Mechanism-Based Diagnostic Criteria	26
Hyperuricemia, Gout, and the Brain—an Update	24
Mitochondria in the Pathogenesis of Systemic Lupus Erythematosus	24
Updates on the Immunopathology in Idiopathic Inflammatory Myopathies	24
Involvement of Macrophages and Spinal Microglia in Osteoarthritis Pain	23
Axial Psoriatic Arthritis	22
Metabolic Regulation of Tendon Inflammation and Healing Following Injury	22

An Update on Antiphospholipid Syndrome	22
IgA Vasculitis in Adults: a Rare yet Challenging Disease	21
Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist	21
Etiologies of Rheumatoid Arthritis: Update on Mucosal, Genetic, and Cellular Pathogenesis	21
Future of Low-Dose Computed Tomography and Dual-Energy Computed Tomography in Axial Spondyloarthritis	21
The Musculoskeletal Manifestations of Marfan Syndrome: Diagnosis, Impact, and Management	21
Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis	21
SARS-CoV-2 and Systemic Lupus Erythematosus	20
A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis?	20
Gut Microbiota in Lupus: a Butterfly Effect?	20
Self-Management of Rheumatoid Arthritis: Mobile Applications	19
TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals	18
Exogenous miRNA: A Perspective Role as Therapeutic in Rheumatoid Arthritis	18
A Spotlight on Drug-Induced Vasculitis	18
ANCA Status or Clinical Phenotype — What Counts More?	18
Novel Therapies for ANCA-associated Vasculitis	18
Who Would Have Predicted Multisystem Inflammatory Syndrome in Children?	17
Imaging of Joint and Soft Tissue Involvement in Systemic Lupus Erythematosus	17
Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections)	17
Modification of Gut Microbiota in Inflammatory Arthritis: Highlights and Future Challenges	16
The Role of Antiphospholipid Antibodies in COVID-19	16
Update on Uric Acid and the Kidney	16
Autonomic Nervous System Dysregulation and Osteoarthritis Pain: Mechanisms, Measurement, and Future Outlook	15
Mesangial Cells in Lupus Nephritis	15
NETosis in Rheumatic Diseases	15
JAK Inhibitors for Axial Spondyloarthritis: What does the Future Hold?	15
COVID-19 and Disease-Modifying Anti-rheumatic Drugs	15
Spectrum of Spondyloarthritis Among Chinese Populations	14
Treatment of Calcinosis in Juvenile Dermatomyositis	14
Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management	14
The Microbiome in Osteoarthritis: a Narrative Review of Recent Human and Animal Model Literature	14
Enthesitis in Psoriatic Arthritis, the Sonographic Perspective	14
The Interplay of Biomechanical and Biological Changes Following Meniscus Injury	14
Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)	13
Persistent Joint Pain Following Arthropod Virus Infections	13
MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis	12
Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis	12
Worldwide Differences in Clinical Phenotype of Axial Spondyloarthritis	12
Beyond Giant Cell Arteritis and Takayasu’s Arteritis: Secondary Large Vessel Vasculitis and Vasculitis Mimickers	12
Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis	11
The Nasal Microbiome in ANCA-Associated Vasculitis: Picking the Nose for Clues on Disease Pathogenesis	11
Localized Forms of Vasculitis	11
Drivers of Inflammation in Psoriatic Arthritis: the Old and the New	11
Differential Metabolome in Rheumatoid Arthritis: a Brief Perspective	10
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms	10
Update on Biomarkers of Vasculopathy in Juvenile and Adult Myositis	10
Imaging in Axial Spondyloarthritis: What is Relevant for Diagnosis in Daily Practice?	10
Trabecular Bone Score in Rheumatic Disease	10
A Review of Difficult-to-Treat Rheumatoid Arthritis: Definition, Clinical Presentation, and Management	10
Clinical Characteristics of Myositis Associated with Graft-Versus-Host Disease	10

Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update	10
Spectrum of Large and Medium Vessel Vasculitis in Adults: Primary Vasculitides, Arthritides, Connective Tissue, and Fibroinflammatory Diseases	9
Anatomical Joint Form Variation in Sacroiliac Joint Disease: Current Concepts and New Perspectives	9
Cannabis for Rheumatic Disease Pain: a Review of Current Literature	9
Undifferentiated Connective Tissue Disease: Comprehensive Review	9
What Has Dual Energy CT Taught Us About Gout?	9
Familial Mediterranean Fever: How to Interpret Genetic Results? How to Treat? A Quarter of a Century After the Association with the Mefv Gene	9
Neurosarcoidosis: Phenotypes, Approach to Diagnosis and Treatment	9
COVID-19: What Do Rheumatologists Need to Know?	8
Beyond Medical Treatment: Surgical Treatment of Gout	8
At the Heart of Eosinophilic Granulomatosis with Polyangiitis: into Cardiac and Vascular Involvement	8
Neuromodulation as a Potential Disease-Modifying Therapy for Osteoarthritis	7
Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use	7
Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases	7
Enzymatic Machinery of Ubiquitin and Ubiquitin-Like Modification Systems in Chondrocyte Homeostasis and Osteoarthritis	7
Update on Post-Streptococcal Reactive Arthritis: Narrative Review of a Forgotten Disease	7
Idiopathic Orbital Myositis Revisited	7
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management	7
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response	7
Something Old, Something New: the ACR Gout Treatment Guideline and Its Evolution from 2012 to 2020	7
Treat-to-Target in Pediatric Rheumatic Diseases	6
Chondrocalcinosis: Advances in Diagnostic Imaging	6
Interstitial Lung Disease in ANCA-Associated Vasculitis: Pathogenic Considerations and Impact for Patients’ Outcomes	6
The Potential Role of Probiotics in the Management of Osteoarthritis Pain: Current Status and Future Prospects	6
Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis?	6
Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review	6
Intersections Between Mitochondrial Metabolism and Redox Biology Mediate Posttraumatic Osteoarthritis	6
Update on Cutaneous Signs to Assist in the Diagnosis of Dermatomyositis	6
Axial Spondyloarthritis and Diagnostic Challenges: Over-diagnosis, Misdiagnosis, and Under-diagnosis	6
Value-Based Healthcare in Rheumatology: Axial Spondyloarthritis and Beyond	6